|
Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data.
Semin Thromb Hemost. 2006 Abr; 32(3):276-82.
Finazzi G. |
|
Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
Semin Thromb Hemost. 2006 Abr; 32(3):251-9.
Landolfi R, Di Gennaro L, Novarese L, Patrono C. |
|
Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Semin Thromb Hemost. 2006 Abr; 32(3):174-207.
Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W. |
|
The platelet P2 receptors in arterial thrombosis.
Blood Cells Mol Dis. 2006 Abr; 36(2):223-7. Epub 2006 Feb 8. Feb
Gachet C, Leon C, Hechler B. |
|
Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.
Thromb Res. 2006 Mar;
Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS. |
|
High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome.
J Thromb Haemost. 2006 Mar; 4(3):542-9.
Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, Bonnet JL, Alessi MC. |
|
P2Y receptor-mediated potentiation of thrombin-induced thromboxane A generation in platelets occurs through regulation of Erk1/2 activation.
J Thromb Haemost. 2006 Mar; 4(3):638-47.
Shankar H, Garcia A, Prabhakar J, Kim S, Kunapuli SP. |
|
Platelet activation in hemolytic uremic syndrome.
Semin Thromb Hemost. 2006 Mar; 32(2):128-45.
Karpman D, Manea M, Vaziri-Sani F, Stahl AL, Kristoffersson AC. |
|
Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
J Am Coll Cardiol. 2006 Feb; 47(3):541-6. Epub 2006 Ene 18
Cooke GE, Liu-Stratton Y, Ferketich AK, Moeschberger ML, Frid DJ, Magorien RD, Bray PF, Binkley PF, Goldschmidt-Clermont PJ. |
|
Aspirin resistance: mechanisms and clinical implications.
Cardiol Rev. 2006 Feb; 14(1):18-25.
Hanjis C, Frishman WH, Lerner RG. |
|
The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets.
Br J Haematol. 2006 Feb; 132(4):494-502.
O´Halloran AM, Curtin R, O´Connor F, Dooley M, Fitzgerald A, O´Brien JK, Fitzgerald DJ, Shields DC. |
|
Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
Thromb Haemost. . 2006 Feb; 95(2):253-9.
Lepantalo A, Mikkelsson J, Resendiz JC, Viiri L, Backman JT, Kankuri E, Karhunen PJ, Lassila R. |
|
A new definition of aspirin non-responsiveness by platelet function analyzer-100 and its predictors.
Platelets. 2006 Feb; 17(1):7-13.
Abaci A, Caliskan M, Bayram F, Yilmaz Y, Cetin M, Unal A, Cetin S. |
|
MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2´-deoxyadenosine-3´,5´-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice.
J Pharmacol Exp Ther. 2006 Feb; 316(2):556-63. Epub 2005 Oct 19
Hechler B, Nonne C, Roh EJ, Cattaneo M, Cazenave JP, Lanza F, Jacobson KA, Gachet C. |
|
The role of platelets during reproduction.
Pathophysiol Haemost Thromb. 2006 Ene; 35(1-2):23-7.
Isermann B, Nawroth PP. |
|
Impact--the cone and plate(let) analyzer: testing platelet function and anti-platelet drug response.
Pathophysiol Haemost Thromb. 2006 Ene; 35(1-2):83-8.
Savion N, Varon D. |
|
The role of platelets during reproduction.
Pathophysiol Haemost Thromb. 2006 Ene; 35(1-2):23-7.
Isermann B, Nawroth PP. |
|
Thrombotic thromboytopenic purpura: another example of immunomediated thrombosis.
Pathophysiol Haemost Thromb. . 2006 Ene; 35(1-2):89-97.
Manucci PM. |
|
Detecting bacterial contamination in platelet products.
Clin Lab. 2006 Ene; 52(9-10):443-56.
Palavecino EL, Yomtovian RA, Jacobs MR. |
|
The Interaction between Lipoproteins and Platelets.
Pathophysiol Haemost Thromb. 2006 Ene; 35(3-4):269-.
Akkerman JW. |
